Remove global-development global-health
article thumbnail

Opinion: The world is relying on the United States to get value-based drug pricing right

STAT

has implications for the global pace and direction of innovation. Drug policy changes are being influenced by perceptions of the value of novel medicines relative to their budgetary impacts, with some believing that many medicines may not be worth their cost, creating an important role for health technology assessments (HTA).

article thumbnail

STAT+: Assistants, not replacements: How AI can accelerate research and health care

STAT

At a panel at the Milken Institute 2024 Global Conference Monday, Bastani and other health care leaders addressed the rapidly growing applications of AI in science and health care. Collectively, they acknowledged that developers and health systems have to think critically about AI’s limits to avoid harm to patients.

332
332
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

WHO recommends second malaria vaccine, hoping to address supply issues

STAT

Just two years after the World Health Organization’s historic recommendation of the first malaria vaccine, the global health agency on Monday recommended a second , seeking to broaden access to a tool it hopes can save lives.

Vaccines 342
article thumbnail

STAT+: Life science leaders on how to make drug development less expensive, slow, and risky

STAT

Drug development is essentially a long, expensive bet: 90% of drugs fail during clinical trials, goes one of the life science industry’s most oft-quoted statistics. But they cautioned that the pace of future successes will depend on whether the industry can streamline and rethink drug development.

article thumbnail

STAT+: Health care leaders plot how to expand diversity in clinical trials

STAT

The work of bringing diversity to research is complex, and several experts gathered at the Milken Institute Global Conference on Wednesday to discuss potential strategies to make progress, starting with ways to build trust among the communities that have a history of being mistreated or exploited by the scientific community.

325
325
article thumbnail

Opinion: To learn lessons from pandemics, don’t listen to big pharma

STAT

Early in the Covid-19 pandemic, the leaders of wealthy countries pledged to respond with “global solidarity.” When governments of high-income countries belatedly responded to the threat, they sided with pharmaceutical companies that were extracting profits from a global health crisis. Read the rest…

Vaccines 315
article thumbnail

Opinion: How the world can end Covid-19 as a public health threat

STAT

The journal Nature published today global consensus recommendations to end Covid-19 as a public health threat. There have been times when we wondered if it was worth the effort.

350
350